All lobbying filings

Tenagrity Solutions, LLC

Tenagrity Solutions, LLC filed a Q1 termination report for CBA Pharma Inc. on April 20, 2026, reporting $10,000 in lobbying income.

Lobbying for CBA Pharma Inc. · biopharmaceutical company

As filed: TENAGRITY SOLUTIONS, LLC for CBA PHARMA INC.

All filings by Tenagrity Solutions, LLC · Everything CBA Pharma Inc. has reported

Filing · LD-2 quarterly report Q1 termination

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

Kentucky

Representation ended

Feb 28, 2026

The registrant reported terminating its work for this client.

Official filing document

Lobbyists on this filing 1

JENNY CAROLINE DEBERRY

Previously held: Senior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Law Enforcement/Crime/Criminal Justice

Raising awareness amongst DOJ officials of the company's challenges as it attempts to move forward with its drug.

Health Issues

Raising awareness amongst appropriate HHS officials of the company's challenges as it attempts to move forward with its drug.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.